USANA HEALTH SCIENCES, INC. Payments to Acquire Assets, Investing Activities
USANA HEALTH SCIENCES, INC. (USNA) reported Payments to Acquire Assets, Investing Activities of $0 for the 12-month period ending 2023-12-30, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAssetsInvestingActivities · last filed 2024-02-27
- USANA HEALTH SCIENCES, INC. payments to acquire assets, investing activities for the quarter ending 2023-12-30 was $0.00.
- USANA HEALTH SCIENCES, INC. payments to acquire assets, investing activities for the quarter ending 2023-09-30 was $0.00.
- USANA HEALTH SCIENCES, INC. payments to acquire assets, investing activities for the quarter ending 2022-12-31 was $0.00.
- USANA HEALTH SCIENCES, INC. payments to acquire assets, investing activities for the quarter ending 2022-10-01 was $0.00.
- USANA HEALTH SCIENCES, INC. payments to acquire assets, investing activities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. payments to acquire assets, investing activities for fiscal 2022 was $6.53M.
- USANA HEALTH SCIENCES, INC. payments to acquire assets, investing activities for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Assets, Investing Activities 3 month | Payments to Acquire Assets, Investing Activities 6 month | Payments to Acquire Assets, Investing Activities 9 month | Payments to Acquire Assets, Investing Activities 12 month |
|---|---|---|---|---|
| 2023-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||
| 2023-07-01 | $0.00 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $6.53M 10-K · filed 2024-02-27 | |
| 2022-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $6.53M 10-Q · filed 2023-11-07 | ||
| 2022-07-02 | $6.53M 10-Q · filed 2023-08-08 | |||
| 2022-01-01 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |
| 2021-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-07-03 | $0.00 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |